Clinical significance of major and minor bcr/abl chimeric transcripts in essential thrombocythemia

Jpn J Clin Oncol. 2000 Nov;30(11):472-7. doi: 10.1093/jjco/hyd122.

Abstract

Background: Contradictory results have been reported in terms of detecting bcr/abl transcripts in patients with essential thrombocythemia. The aim of this study was to investigate whether the bcr/abl transcript could be found in patients with essential thrombocythemia (ET).

Methods: The bcr/abl transcript was amplified by the RT-nested PCR method using RNA extract from leukocytes taken from 14 essential thrombocythemia patients. The amplified DNAs were electrophoresed in 1% agarose and visualized with ethidium bromide. The DNA bands associated with the bcr/abl transcript were then extracted and followed by DNA sequence analysis.

Results: Major bcr/abl transcripts of the b3a2 type and minor ones of the e1a2 type were found in one and two ET patients, respectively. The incidence of bcr/abl transcripts was 21.4% (three of 14 patients).

Conclusion: Our experiments confirmed that bcr/abl transcripts are present in some patients with essential thrombocythemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Fusion Proteins, bcr-abl / genetics*
  • Humans
  • Male
  • Middle Aged
  • Oncogene Proteins, Fusion / genetics*
  • Recombinant Fusion Proteins / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thrombocythemia, Essential / genetics*
  • Transcription, Genetic*

Substances

  • Oncogene Proteins, Fusion
  • Recombinant Fusion Proteins
  • Fusion Proteins, bcr-abl